drugset / Trial / NCT03887299

Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery

NCT03887299

Phase 4 Completed 154 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupOpen-labelTreatment

Summary

This will be an open label pilot randomized controlled clinical trial. Women undergoing cesarean delivery will be randomized to have standard wound dressing care or chlorohexidine gluconate (CHG) impregnated wound dressing (ReliaTect™ Post-Op Dressing).

Timeline

Start
2019-04-18
Primary completion
2020-01-18
Completion
2020-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorohexidine Gluconate Unknown Topical

Indications